Skip to main content

Breadcrumb

  1. Home

Elderly

Annual cervical cancer screening or follow-up in high-risk women

  • This measure identifies women age 12 to 65 diagnosed with cervical dysplasia (CIN 2), cervical carcinoma-in-situ, or HIV/AIDS prior to the measurement year, and who still have a cervix, who had a cervical CA screen during the measurement year.

    CBE ID
    0579

Annual Monitoring for Patients on Persistent Medications (MPM)

  • This measure assesses the percentage of patients 18 years of age and older who received a least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. Report the following three rates and a total rate:

    CBE ID
    2371

Anti-Lipid Treatment Discharge

  • Percent of patients aged 18 years and older undergoing isolated CABG who were discharged on a lipid lowering statin

    CBE ID
    0118

Antipsychotic Use in Persons with Dementia

  • The percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

    A lower rate indicates better performance.

    CBE ID
    2111

APPROPRIATE FOLLOW-UP FOR PATIENTS WITH HIV

  • To ensure that all members diagnosed with HIV receive at least annual testing for CD4 and at least biannual HIV RNA levels to monitor for disease activity.

    CBE ID
    0568

Aspirin at Arrival

  • Percentage of emergency department acute myocardial infarction (AMI) patients or chest pain patients (with Probable Cardiac Chest Pain) without aspirin contraindications who received aspirin within 24 hours before ED arrival or prior to transfer.

    CBE ID
    0286